Valid Inside Market Submission definition

Valid Inside Market Submission means a submission from a Participating Bidder received by the Administrators during the Initial Bidding Period of both an Inside Market Bid and an Inside Market Offer, each expressed as a percentage (in increments of one-eighth of one percentage point (e.g., 35.375%), but not less than 0.00%) which do not differ from one another by more than 3.00%, and for which the Inside Market Bid is not greater than or equal to the Inside Market Offer.Exhibit 1 to LCDS Auction Settlement Terms Form of Bidding Agreement Letter [Letterhead of Participating Bidder] [Date] Markit Group Limited Send to: cea@markit.com Creditex Securities Corp. Send to: CEF@creditex.com International Swaps and Derivatives Association, Inc. Send to: AlerisAuctionACCIProtocol@isda.org Markit North America, Inc. c/o Markit Group Limited Dear Sirs, We write to inform you that we wish to be a “Participating Bidder,” as defined in the LCDS Auction Settlement Terms (the “Auction Terms”) in connection with the auction under the Auction Terms related to First Lien transactions with respect to Aleris International,Idearc Inc. (the “Auction”). Capitalized terms used in this letter but not defined herein have the meanings specified in the Auction. We hereby notify you that it is our intention that, pursuant to the Auction Terms at the time of submission, any Dealer Physical Settlement Request we submit will, to the best of our knowledge and belief, be in the same direction as and will not exceed our Market Position. By signing and returning this Bidding Agreement Letter to you, we represent that:
Sample 1
Valid Inside Market Submission means a submission from a Participating Bidder received by the Administrators during the Initial Bidding Period of both an Inside Market Bid and an Inside Market Offer, each expressed as a percentage (in increments of one-eighth of one percentage point (e.g., 35.375%)) of the outstanding principal balance (rather than the face amount) of Deliverable Obligations which do not differ from one another by more than 2.00% of par, and for which the Inside Market Bid is not greater than or equal to the Inside Market Offer.EXHIBIT 3to 2008 Tribune CDS Protocol Form of Bidding Agreement Letter [Letterhead of Participating Bidder] [Date]Markit Group Limited Send to: cdx@markit.com Creditex Securities Corp.Send to: CEF@creditex.comInternational Swaps and Derivatives Association, Inc. Send to: TribuneProtocol@isda.org Dear Sirs, We write to inform you that we wish to be a "Participating Bidder" in respect of the Auction occurring pursuant to the 2008 Tribune CDS Protocol, as published by the International Swaps and Derivatives Association, Inc. on December 16, 2008 (the "Protocol"), in respect of Tribune. Capitalized terms used in this letter but not defined herein have the meanings specified in the Protocol. We hereby notify you that it is our intention that, pursuant to the terms of the Protocol at the time of submission, any Dealer Physical Settlement Request we submit will, to the best of our knowledge and belief, be in the same direction as and will not exceed our Market Position. By signing and returning this Bidding Agreement Letter to you, we represent that:
Sample 1
Valid Inside Market Submission means a submission from a Participating Bidder consisting of both an Inside Market Bid and an Inside Market Offer, each expressed as a percentage (in increments of one eighth of one percent (e.g., 35.375%) but not less than 0.00%) which do not differ from one another by more than 5%, and for which the Inside Market Bid is not greater than or equal to the Inside Market Offer. Exhibit 1 to ELCDS Cancellable and Non-Cancellable Auction Settlement Terms for Mediannuaire Pages Jaunes First Lien Loans Form of Bidding Agreement Letter [Letterhead of Participating Bidder] [Date] Markit Group Limited Send to: cea@markit.com Creditex Brokerage LLP Send to: CEF@creditex.com International Swaps and Derivatives Association, Inc. Send to: ceba@isda.org International Index Company Ltd. Send to: itraxx@indexco.com Dear Sirs, We write to inform you that we wish to be a "Participating Bidder," as defined in the ELCDS Cancellable and Non-Cancellable Auction Settlement Terms (the "Auction Terms") in connection with the auction under the ELCDS Cancellable and Non-Cancellable Auction Settlement Terms related to transactions with respect to Mediannuaire Pages Jaunes First Lien Loans (the "Auction"). Capitalised terms used in this letter but not defined herein have the meanings specified in the Auction Terms. We hereby notify you that it is our intention that, pursuant to the Auction Terms at the time of submission, any Dealer Physical Settlement Request we submit will, to the best of our knowledge and belief, be in the same direction as, and will not exceed, our Market Position. By signing and returning this Bidding Agreement Letter to you, we represent, as of the date of this Bidding Agreement Letter, that:
Sample 1

More Definitions of Valid Inside Market Submission

Valid Inside Market Submission means a submission from a Participating Bidder received by the Administrators during the Initial Bidding Period of both an Inside Market Bid and an Inside Market Offer, each expressed as a percentage (in increments of one-eighth of one percentage point (e.g., 35.375%)) of the outstanding principal balance (rather than the face amount) of Deliverable Obligations which do not differ from one another by more than 2.00% of par, and for which the Inside Market Bid is not greater than or equal to the Inside Market Offer.EXHIBIT 3to 2009 Ecuador CDS Protocol Form of Bidding Agreement Letter [Letterhead of Participating Bidder] [Date]Markit Group Limited Send to: cea@markit.com Creditex Securities Corp.Send to: CEF@creditex.comInternational Swaps and Derivatives Association, Inc. Send to: EcuadorProtocol@isda.org Dear Sirs, We write to inform you that we wish to be a "Participating Bidder" in respect of the Auction occurring pursuant to the 2009 Ecuador CDS Protocol, as published by the International Swaps and Derivatives Association, Inc. on January 6, 2009 (the "Protocol"), in respect of Ecuador. Capitalized terms used in this letter but not defined herein have the meanings specified in the Protocol. We hereby notify you that it is our intention that, pursuant to the terms of the Protocol at the time of submission, any Dealer Physical Settlement Request we submit will, to the best of our knowledge and belief, be in the same direction as and will not exceed our Market Position. By signing and returning this Bidding Agreement Letter to you, we represent that:
Sample 1

Related to Valid Inside Market Submission

  • Regulatory Information Service means a regulatory information service as defined in the Takeover Rules.

  • FDA means the United States Food and Drug Administration and any successor agency thereto.

  • Client Application means an application developed by Licensee that a) utilizes the Runtime Product, b) is installed fully on an end user’s machine, with all report processing local to that machine, and c) adds significant and primary functionality to the Runtime Product.

  • Research record means any data, document, computer file, computer diskette, or any other written or non-written account or object that reasonably may be expected to provide evidence or information regarding the proposed, conducted, or reported research that constitutes the subject of an allegation of research misconduct. A research record includes, but is not limited to, grant or contract applications, whether funded or unfunded; grant or contract progress and other reports; laboratory notebooks; notes; correspondence; videos; photographs; X-ray film; slides; biological materials; computer files and printouts; manuscripts and publications; equipment use logs; laboratory procurement records; animal facility records; human and animal subject protocols; consent forms; medical charts; and patient research files.

  • Marketing Approval Application or “MAA” means a New Drug Application (or its equivalent), as defined in the U.S. Food, Drug and Cosmetic Act and the regulations promulgated thereunder, or any corresponding or similar application, registration or certification in any country.

  • Research Results means any technical result acquired based on the Collaborative Research, including, but not limited to, any invention, idea, design, copyrightable work and know-how which relates to the purpose of the Collaborative Research.

  • Core Curriculum Content Standards means the New Jersey Student Learning Standards.

  • Regulatory Approval Application means any application submitted to an appropriate Regulatory Authority seeking any Regulatory Approval.

  • Approval Application means a BLA, NDA or similar application or submission for a Product filed with a Regulatory Authority in a country or group of countries to obtain marketing approval for a biological or pharmaceutical product in that country or group of countries.

  • Biosimilar Application has the meaning set forth in Section 7.3.3.

  • Public Procurement Regulatory Authority (PPRA) means the Government Agency responsible for oversight of public procurement.

  • Regulatory Authorities means the Commissions and the Exchange;

  • Regulatory Floodway means the channel of a river or other watercourse and the adjacent land areas that must be reserved in order to discharge the base flood without cumulatively increasing the water surface elevation more than a designated height.

  • Regulatory Submissions means any filing, application or submission with any Regulatory Authority, including authorizations, approvals or clearances arising from the foregoing, including Regulatory Approvals and any pricing or reimbursement approvals, as applicable, and all correspondence or communication with or from the relevant Regulatory Authority, as well as minutes of any material meetings, telephone conferences or discussions with the relevant Regulatory Authority, in each case, with respect to a Licensed Product.

  • Massive Multiauthor Collaboration Site (or “MMC Site”) means any World Wide Web server that publishes copyrightable works and also provides prominent facilities for anybody to edit those works. A public wiki that anybody can edit is an example of such a server. A “Massive Multiauthor Collaboration” (or “MMC”) contained in the site means any set of copyrightable works thus published on the MMC site.

  • Supplemental Marketing Material means any Issuer Free Writing Communication other than any Issuer Free Writing Communication specified in Schedule B hereto. Supplemental Marketing Materials include, but are not limited to, any Issuer Free Writing Communication listed on Schedule C hereto.

  • Clinical Trials means a controlled study in humans of the safety or efficacy of a Product, and includes, without limitation, such clinical trials as are designed to support expanded labeling or to satisfy the requirements of an Agency in connection with any Product Approval and any other human study used in research and Development of a Product.

  • BLA means a Biologics License Application under the United States’ Public Health Services Act and Federal Food, Drug and Cosmetics Act, each as amended, and the regulations promulgated thereunder, or a comparable filing seeking Regulatory Approval in any country.

  • Reporting Insider means an insider of a reporting issuer if the insider is

  • Marketing Authorization Application or “MAA” means an application for Regulatory Approval (but excluding Pricing Approval) in any particular jurisdiction other than the U.S.

  • Marketing Information means marketing studies, marketing analyses, and similar research and information designed to identify potential customers and business relationships.

  • Marketing Approval means all approvals, licenses, registrations or authorizations of the Regulatory Authority in a country, necessary for the manufacture, use, storage, import, marketing and sale of a Product in such country.

  • Advertising Materials means all advertising, merchandising, promotional and display materials of or concerning the Licensed Products.

  • Drug Approval Application means an application for Regulatory Approval required before commercial sale of a Product as a pharmaceutical product in a regulatory jurisdiction.

  • Practical application means to manufacture in the case of a composition or product, to practice in the case of a process or method, or to operate in the case of a machine or system; and, in each case, under such conditions as to establish that the invention is being utilized and that its benefits are, to the extent permitted by law or government regulations, available to the public on reasonable terms.

  • Clinical Studies means human clinical trials for a Licensed Product and any other tests and studies for a Licensed Product in human subjects.